New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patien ...

Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that ...

Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA ...

Age-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 ...

The Company also notes that Megan Baldwin, PhD, MAICD, retired from the Board as Executive Director, in accordance with ASX Listing Rules. Dr. Baldwin will continue to advance Opthea’s innovation ...

It's normal for your eyes to change as you age, but these four expert-approved tips can help improve your eye health.

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.

Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating ...

Peking University researchers have developed a deep learning-based, noninvasive choroidal angiography method that enables ...